Valuate Health Consultancy

We help life sciences manufacturers and healthcare stakeholders develop and execute their value strategies to increase market access. Our consulting practice combines deep market access and reimbursement expertise with advanced analytics and insights to demonstrate value to healthcare entities. An extensive market access advisor network and innovative research methods inform a strategic approach to access and reimbursement. Our team of former payers and PBM executives, biopharma market access executives, pharmacists, data scientists, and business strategists work together to solve market access challenges. We help drug and device manufacturers evaluate reimbursement potential for new assets, design and translate health economics evidence,...

Market access strategy,organized customers,payers,access and reimbursement,specialty pharmacy,oncology,patient access programs,health economics strategy,market research,market access,pharma,biotech,biopharma,rare disease,data analytics,pull-through,cell and gene therapy,and value-based contracts

Valuate health consultancy operates in the Business consulting and services industry.

Valuate health consultancy's revenue is 11m - 100m

Valuate health consultancy has 11 - 50 employees.